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Abstract
A 38-year-old multiparous woman with post thyroidectomy hypoparathyroidism developed
pruritic erythematous patches with multiple pustules on its margins on her thighs and groin
accompanied by fever few days after delivery by caesarean section. Impetigo herpetiformis was
diagnosed based on the typical clinicopathological findings. The patient was treated with
intravenous fluids, calcium, Calcitrol and corticosteroids. The correction of hypocalcaemia was
accompanied with rapid improvement of her skin disease and general condition. Our case is the
fourth case of impetigo herpetiformis initially presented during puerperium and the first case of
puerperal impetigo herpetiformis that is precipitated by secondary hypoparathyroidism. The
awareness of the possible occurrence of impetigo herpetiformis during the puerperium allows early
diagnosis, treatment and prevention of maternal complications.
Case presentation
A 38-year-old Egyptian woman was admitted to Cairo
University Hospital with extensive exfoliation of her skin.
Two weeks prior to her admission, she delivered a healthy
baby by uncomplicated caesarian section.
Few days after her delivery, she developed pruritic ery-
thematous patches with multiple pustules on its margins
on her thighs, groins and abdominal wall. She was treated
empirically with hydrocortisone 1% cream. Few days
later, the rash progressed and involved most of her body,
she felt weak and developed chills. On examination, she
appeared ill with a blood pressure of 90/60, pulse rate of
120/min, temperature of 38°C and respiratory rate of 20/
min.
She had erythroderma, multiple crusted plaques and
extensive skin exfoliation of her trunk and extremities
sparing her eyes and mucous membranes (Figure 1).
There were no nails abnormalities noted. Chvostek and
Trousseau signs were negative. There were no personal or
family history of similar condition.
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during the second trimester. She developed secondary
hypoparathyroidism after surgery. She was not compliant
with her medications which included calcium, L-thyrox-
ine and vitamin D.
Laboratory studies revealed leucocytic count of 21.500/ml
(normal 4300-10800/ml) with 84% neutrophils (normal
45%-74%), total calcium 5.2 mg/dl (normal 8.5-10.5 mg/
dl), phosphorus 5 mg/dl (normal 2.5-4.5 mg/dl), albu-
min 3.2 gm/dl (normal 3.5-5.5 gm/dl), blood urea nitro-
gen 64 mg/dl (normal 10-20 mg/dl), creatinine 1.4 mg/dl
(normal < 1.5 mg/dl). Thyroid stimulating hormone 38.3
μU/ml (normal 0.4-0.6 μU/ml), thyroxine 0.39 Pmol/ml
(normal 9-24 Pmol/ml) and parathormone 6.1 Pg/ml
(normal 11-54 Pg/ml).
Intravenous fluids, oral prednisone 60 mg/d, calcium glu-
conate 2 g/d, Calcitrol 0.25 μg/d, intravenous clindamy-
cin 1200 mg/d and intravenous vancomycin 1 g/day were
given. The correction of hypocalcaemia (within five days)
was accompanied with rapid improvement of her skin dis-
ease and general condition, indicating the importance of
correction of hypocalcaemia in patients with impetigo
herpetiformis precipitated by hypoparathyroidism [1].
The skin biopsy was consistent with pustular psoriasis.
(Figure 2)
The patient was discharged from the hospital three weeks
after her admission with near complete recovery of her
skin (Figure 3).
Hebra introduced the term impetigo herpetiformis (IH) to
described five pregnant women, all of them were in toxic
condition, febrile and had extensive pustular eruption.
Hebra classified it as a specific dermatosis of pregnancy
[2]. IH usually present during the third trimester with a
progressive course during pregnancy and then rapid reso-
lution occurs during the puerperium. Few cases similar to
our case were initially reported during the puerperium [3-
5].
It is controversial, whether IH is a form of generalized pus-
tular psoriasis based on the identical histopathology, or a
Erythroderma, multiple crusted plaques and pustules in lower limbFigure 1
Erythroderma, multiple crusted plaques and pustules in lower limb.
Subcorneal spongiform pustules containing numerous neu-trophilsFigure 2
Subcorneal spongiform pustules containing numer-
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of psoriasis, the association with pregnancy and hypocal-
caemia, its recurrence with subsequent pregnancies and
the absence of development of chronic plaque psoriasis
might suggest that IH is a distinct entity [1,6,7].
IH presents mainly by pustular eruption that begins sym-
metrically in the flexural and intertriginous areas and then
extends centrifugally. The lesions are erythematous
patches with sterile pustules at their margins. They form
plaques and pustules that become eroded, then crusted.
Generalized eruption and even exfoliation of the whole
body can also occur as in our case. Mucous membranes
can be also affected [6].
IH is usually associated with systemic features as fever,
sweating, tachycardia, nausea, diarrhea, vomiting, lym-
phadenopathy, splenomegaly and tetany, in severe cases
renal or cardiac failure may occur. Moreover, IH is associ-
ated with increased incidence of congenital anomalies
and placental insufficiency resulting in increased risk of
intrauterine growth retardation, stillbirth and neonatal
deaths [7].
Although hypocalcemia in many cases of IH may be a sec-
ondary phenomenon due to extensive skin inflammation
that result in extravasation of albumin and calcium
bounded to it to the interstitial space [8]. It had been
established that IH could be precipitated by hypoparathy-
roidism and hypocalcaemia, and could be cured by cor-
rection of hypocalcaemia in patients with
hypoparathyroidism. Moreover there are several reports
of IH occurring in men and non pregnant women with
hypoparathyroidism and hypocalcaemia, suggesting the
triggering role of hypocalcaemia in the disease process
[1,8]. Katsambas et al suggested that the decrease of serum
calcium (main decrease is in nonionized fraction with
mild decrease in ionized calcium) and vitamin D during
pregnancy and puerperium play a role in the development
of IH during pregnancy and puerperium [3].
There are no guidelines for IH treatment. Fluid and elec-
trolytes especially calcium should be monitored and nor-
malized [1]. Corticosteroids are commonly used [6,7].
There are reports of successful treatment of IH during
pregnancy with cyclosporine [9]. Other studies reported
that Retinoids, methotrexate, psoralen and ultraviolet A
(PUVA) can be used successfully during puerperium [6,7].
Conclusion
According to the best of our knowledge this is the fourth
case of impetigo herpetiformis initially presented during
the puerperium and the first case of puerperal impetigo
herpetiformis that is precipitated by secondary hypopar-
athyroidism. The awareness of the possible occurrence of
IH during the puerperium allows early diagnosis, treat-
ment and prevention of possible serious maternal compli-
cations.
Abbreviations
IH: impetigo herpetiformis; PUVA: psoralen and ultravio-
let A.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All the authors analyzed and interpreted the patient data.
UMF, RMF and HMA were involved in manuscript writ-
ing. M.E performed the histological examination of the
skin lesions. All the authors approved the final manu-
script.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
References
1. Moynihan GD, Ruppe JP Jr: Impetigo herpetiformis and
hypoparathyroidism.  Arch Dermatol 1985, 121(10):1330-1331.
2. Hebra F: Ueber einzelne wahrend Schwangerschaft, des
wacherbette unde bei uterinal. Krankheiten der Frauen zu
beobachtende Hautkrankheiten.  Wien Med Wochenschr 1872,
48:1197-1202.
3. Katsambas A, Stavropoulos PG, Katsiboulas V, Kostakis P, Panayi-
otopoulos A, Christofidou E, Petridis A: Impetigo herpetiformis
during the puerperium.  Dermatology 1999, 198:400-402.
Complete clearing of skin lesions after treatmentFigure 3
Complete clearing of skin lesions after treatment.Page 3 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:9338 http://www.casesjournal.com/content/2/1/9338Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
4. Ross MG, Tucker DC, Hayashi RH: Impetigo herpetiformis as a
cause of postpartum fever.  Obstet Gynecol 1984, 64(3):49S-51S.
5. Park HS, Youn SJ, Sung HT, Kim WS, Lee ES: A Case of Impetigo
Herpetiformis Occurring In Puerperium.  Korean J Dermatol
2004, 42:758-761.
6. Lim KS, Tang MB, Ng PP: Impetigo herpetiformis--a rare derma-
tosis of pregnancy associated with prenatal complications.
Ann Acad Med Singapore 2005, 34(9):565-568.
7. Oumeish OY, Parish JL: Impetigo herpetiformis.  Clin Dermatol
2006, 24(2):101-104.
8. Holm AL, Goldsmith LA: Impetigo herpetiformis associated
with hypocalcaemia.  Arch Dermatol 1991, 127:91-95.
9. Brightman L, Stefanato CM, Bhawan J, Phillips TJ: Third-trimester
impetigo herpetiformis treated with cyclosporine.  J Am Acad
Dermatol 2007, 56(Suppl 2):S62-64.Page 4 of 4
(page number not for citation purposes)
